The race to dominate the drone economy has just entered a new phase. On August 6, 2025, U.S. Transportation Secretary Sean P. Duffy unveiled a sweeping proposal that could dramatically expand where and how drones operate in American skies. The new Beyond Visual Line of Sight (BVLOS) rule aims to remove one of the biggest… Continue reading U.S. Drone Stocks Ready for Liftoff with Groundbreaking FAA Proposal (ZENA, AVAV, KTOS, ONDS)
Mark MCKelvie
Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)
Artificial intelligence is becoming an essential driver of innovation across defense, infrastructure, and enterprise technology sectors. In response, the federal government has introduced “Winning the AI Race: America’s AI Action Plan,” a comprehensive strategy to accelerate AI development, expand domestic manufacturing and data center capacity, and partner exclusively with trusted AI developers. This plan represents… Continue reading Washington’s AI Push Is Accelerating: Here Are 4 Stocks Poised to Benefit (ZENA, GFS, BBAI, INOD)
Four Rising Stars Driving the Next Wave of Stem Cell and Gene Therapy Innovation (AIDA, MESO, LCTX, CRSP)
The global stem cell market is estimated at $15.10 billion in 2024 and is projected to nearly double to $28.89 billion by 2030, growing at a compound annual growth rate of 11.4 percent. This growth is driven by advances in regenerative medicine, increasing investments, and new therapies targeting serious diseases such as cancer, autoimmune disorders,… Continue reading Four Rising Stars Driving the Next Wave of Stem Cell and Gene Therapy Innovation (AIDA, MESO, LCTX, CRSP)
Agriculture Goes High-Tech: Four Drones Stocks Flying High in 2025 (ZENA, UAVS, CNH, AVAV)
The agriculture drone market is exploding. Valued at 6.1 billion dollars in 2024, it is expected to nearly quadruple to 23.8 billion dollars by 2032, growing at a compound annual rate of 18.5 percent. This rapid expansion is driven by rising demand for precision farming tools that improve efficiency, reduce chemical use, and increase crop… Continue reading Agriculture Goes High-Tech: Four Drones Stocks Flying High in 2025 (ZENA, UAVS, CNH, AVAV)
The Pentagon’s 2025 Push: A Spending Spree To Fortify America’s Critical Minerals and Tech, (DPRO, MP, MILIF, PPTA)
The U.S. Department of Defense (DoD) is throwing its financial weight around in 2025, unleashing a spending spree that’s lighting up the markets and positioning companies like Draganfly Inc. (NASDAQ: DPRO | CSE: DPRO), MP Materials Corp. (NYSE: MP), Rare Resource Recycling Inc., Military Metals Corp. (OTCQB: MILIF | CSE: MILI), and Perpetua Resources Corp. (NASDAQ: PPTA) as key players… Continue reading The Pentagon’s 2025 Push: A Spending Spree To Fortify America’s Critical Minerals and Tech, (DPRO, MP, MILIF, PPTA)
Federal Policy Shift Puts U.S. Drone Stocks on the Flight Path to Growth (ZENA, AVAV, KTOS, ONDS)
The U.S. drone industry may be entering a pivotal phase of growth, driven by new federal policies aimed at accelerating domestic innovation and deployment. On July 11, 2025, the Department of Defense announced a major initiative to rapidly expand the use of small, low-cost drones across military units. This move follows a recent executive order… Continue reading Federal Policy Shift Puts U.S. Drone Stocks on the Flight Path to Growth (ZENA, AVAV, KTOS, ONDS)
Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Pipeline Presents Unique Opportunity To Capitalize On Rare Disease Market Worth Over $15 Billion
Now that the SPDR S&P Biotech index is displaying signs of renewed strength, the biotech boom could resume. In the past three months alone, the index has soared by 23% due to a number of factors, such as an increase in high-profile acquisitions and President Trump’s decisions to delay tariffs for drug imports. With the… Continue reading Medicus Pharma Ltd. (NASDAQ:MDCX): Novel Pipeline Presents Unique Opportunity To Capitalize On Rare Disease Market Worth Over $15 Billion
OS Therapies Inc. (NYSE-A: OSTX) Makes Important Strides in Rare Cancer Therapy
The global oncology drug market is currently valued at over 200 billion dollars and is expected to more than double to 532 billion dollars by 2031. This growth is driven not only by rising demand but also by genuine innovation. After years of steady but incremental progress, newer therapies such as antibody drug conjugates and… Continue reading OS Therapies Inc. (NYSE-A: OSTX) Makes Important Strides in Rare Cancer Therapy
$33 Billion for Drones: How the One Big Beautiful Bill Creates a New Defense Boom (ZENA, KTOS, AVAV, LHX)
The One Big Beautiful Bill, also known as H.R. 1, was signed into law by President Trump on July 4, 2025. It delivers one of the largest federal investment packages in recent memory, combining permanent tax changes with over $150 billion in new defense spending and another $150 billion for border security, ICE, and related… Continue reading $33 Billion for Drones: How the One Big Beautiful Bill Creates a New Defense Boom (ZENA, KTOS, AVAV, LHX)
Small Caps, Big Potential: Regenerative Medicine Stocks Positioned for Growth
Regenerative medicine is gaining serious momentum in 2025 as scientific advances, regulatory progress, and payer acceptance converge to push the sector into a new growth phase. The global regenerative medicine market, valued at nearly $28 billion in 2024, is projected to grow at over 16% annually through 2030, driven by rising demand for cell and gene therapies… Continue reading Small Caps, Big Potential: Regenerative Medicine Stocks Positioned for Growth